In this CE activity, expert faculty review anti-VEGF therapies that reduce treatment burden as well as recognize when patients are experiencing suboptimal response and adverse effects. They also assess best practices for referral and overall management of patients with retinal diseases.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/ophthalmology/20240905/extending-dosing-intervals-in-retinal-disease/overview
- Start Date: 2024-09-30 05:00:00
- End Date: 2024-09-30 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.25 hours
Optometry: 1.0 hours - Commercial Support: Source: Regeneron Pharmaceuticals, Inc. - Amount: 104375.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest